You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

VICOPROFEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Vicoprofen patents expire, and what generic alternatives are available?

Vicoprofen is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in VICOPROFEN is hydrocodone bitartrate; ibuprofen. There are twenty-three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate; ibuprofen profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VICOPROFEN?
  • What are the global sales for VICOPROFEN?
  • What is Average Wholesale Price for VICOPROFEN?
Summary for VICOPROFEN
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 5
Clinical Trials: 2
Patent Applications: 193
What excipients (inactive ingredients) are in VICOPROFEN?VICOPROFEN excipients list
DailyMed Link:VICOPROFEN at DailyMed
Drug patent expirations by year for VICOPROFEN
Recent Clinical Trials for VICOPROFEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Icahn School of Medicine at Mount SinaiN/A
Charleston Laboratories, IncPhase 1

See all VICOPROFEN clinical trials

Paragraph IV (Patent) Challenges for VICOPROFEN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
VICOPROFEN Tablets hydrocodone bitartrate; ibuprofen 10 mg/200 mg 020716 1 2006-03-20
VICOPROFEN Tablets hydrocodone bitartrate; ibuprofen 2.5 mg/200 mg 020716 1 2006-02-24

US Patents and Regulatory Information for VICOPROFEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie VICOPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 020716-001 Sep 23, 1997 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VICOPROFEN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie VICOPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 020716-001 Sep 23, 1997 ⤷  Sign Up ⤷  Sign Up
Abbvie VICOPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 020716-001 Sep 23, 1997 ⤷  Sign Up ⤷  Sign Up
Abbvie VICOPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 020716-001 Sep 23, 1997 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for VICOPROFEN

See the table below for patents covering VICOPROFEN around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 0186241 ⤷  Sign Up
Japan S61197517 DRUG COMPOSITION ⤷  Sign Up
Canada 1267847 COMPOSES PHARMACEUTIQUES D'HYDROCODONE/IBUPROFEN ET METHODE (HYDROCODONE/IBUPROFEN PHARMACEUTICAL COMPOSITIONS AND METHOD) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.